×
For best experience we recommend to activate Javascript in your browser.
Recombinant EpCAM (Oportuzumab Biosimilar) antibody
Reactivity: Human
ELISA, FACS, BLI, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Product Details anti-EpCAM (Oportuzumab Biosimilar) Antibody
(hide)
Target
EpCAM (Oportuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for EpCAM (Oportuzumab Biosimilar) antibodies
Human
Expression System
CHO Cells
Clonality
All clonalities for EpCAM (Oportuzumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for EpCAM (Oportuzumab Biosimilar) antibodies
This EpCAM (Oportuzumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Purpose
Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab)
Characteristics
Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for EpCAM (Oportuzumab Biosimilar)
(hide)
Target
EpCAM (Oportuzumab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
P16422
Recently viewed
(hide)